PL3929303T3 - Kompozycje, sposoby i zestawy do diagnozy nowotworu neuroendokrynnego żołądkowo-jelitowo-trzustkowego - Google Patents

Kompozycje, sposoby i zestawy do diagnozy nowotworu neuroendokrynnego żołądkowo-jelitowo-trzustkowego

Info

Publication number
PL3929303T3
PL3929303T3 PL21169154.8T PL21169154T PL3929303T3 PL 3929303 T3 PL3929303 T3 PL 3929303T3 PL 21169154 T PL21169154 T PL 21169154T PL 3929303 T3 PL3929303 T3 PL 3929303T3
Authority
PL
Poland
Prior art keywords
kits
diagnosis
compositions
methods
gastroenteropancreatic neuroendocrine
Prior art date
Application number
PL21169154.8T
Other languages
English (en)
Polish (pl)
Inventor
Irvin Mark MODLIN
Mark Kidd
Ignat Drozdov
Original Assignee
Clifton Life Sciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clifton Life Sciences LLC filed Critical Clifton Life Sciences LLC
Publication of PL3929303T3 publication Critical patent/PL3929303T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/143Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL21169154.8T 2014-09-15 2015-09-15 Kompozycje, sposoby i zestawy do diagnozy nowotworu neuroendokrynnego żołądkowo-jelitowo-trzustkowego PL3929303T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462050465P 2014-09-15 2014-09-15

Publications (1)

Publication Number Publication Date
PL3929303T3 true PL3929303T3 (pl) 2025-04-28

Family

ID=54207775

Family Applications (2)

Application Number Title Priority Date Filing Date
PL21169154.8T PL3929303T3 (pl) 2014-09-15 2015-09-15 Kompozycje, sposoby i zestawy do diagnozy nowotworu neuroendokrynnego żołądkowo-jelitowo-trzustkowego
PL15771837T PL3194618T3 (pl) 2014-09-15 2015-09-15 Kompozycje, sposoby i zestawy do diagnozy nowotworu neuroendokrynnego żołądkowo- jelitowo-trzustkowego

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL15771837T PL3194618T3 (pl) 2014-09-15 2015-09-15 Kompozycje, sposoby i zestawy do diagnozy nowotworu neuroendokrynnego żołądkowo- jelitowo-trzustkowego

Country Status (13)

Country Link
US (3) US10407730B2 (enExample)
EP (2) EP3194618B1 (enExample)
JP (2) JP6782700B2 (enExample)
KR (2) KR20250021631A (enExample)
CN (1) CN107208132A (enExample)
AU (3) AU2015317893B2 (enExample)
CA (1) CA2959670C (enExample)
DK (2) DK3194618T3 (enExample)
ES (2) ES3013599T3 (enExample)
IL (2) IL250867B (enExample)
MX (2) MX386919B (enExample)
PL (2) PL3929303T3 (enExample)
WO (1) WO2016044330A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015317893B2 (en) 2014-09-15 2021-05-20 Clifton Life Sciences LLC Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
BR112019024481A2 (pt) * 2017-05-25 2020-07-14 Liquid Biopsy Research LLC métodos para detecção de melanoma
IL317236A (en) * 2017-11-30 2025-01-01 Liquid Biopsy Res Llc Predicting peptide receptor radiotherapy using gene expression testing
CN108048564B (zh) * 2018-02-09 2021-03-05 中国科学院昆明动物研究所 人glt8d1基因的新用途
SG11202100047YA (en) * 2018-07-30 2021-02-25 Agency Science Tech & Res Method and system for assessing fibrosis in a tissue sample
US20210108259A1 (en) 2019-10-10 2021-04-15 Liquid Biopsy Research LLC Compositions, methods and kits for biological sample and rna stabilization
FR3110764B1 (fr) 2020-05-20 2024-05-10 Quantum Surgical Méthode de prédiction de la récidive d’une lésion par analyse d’images
CN113215255B (zh) * 2021-04-26 2022-04-05 山东天川精准医疗科技有限公司 用于肝癌早期诊断或预后的生物标记物及其用途
WO2024015968A2 (en) * 2022-07-15 2024-01-18 Emendobio Inc. Strategies for knock-ins at aplp2 safe harbor sites
JP2025532965A (ja) * 2022-09-30 2025-10-03 リキッド バイオプシー リサーチ リミティド ライアビリティ カンパニー 唾液での神経内分泌がん検出方法
CN117292755A (zh) * 2023-08-09 2023-12-26 郑州大学 多模态临界边生物标志物识别方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050084883A1 (en) * 2003-08-25 2005-04-21 The Johns Hopkins University School Of Medicine Method of diagnosis and treatment of pancreatic endocrine neoplasms based on differential gene expression analysis
EP3590956A1 (en) 2008-06-12 2020-01-08 Ipsen Bioinnovation Limited Suppression of neuroendocrine diseases
ES2656487T3 (es) * 2011-03-01 2018-02-27 Yale University Evaluación de la respuesta a la terapia de neoplasmas neuroendocrinos gastroenteropancreáticas (GEP-NEN)
AU2015317893B2 (en) 2014-09-15 2021-05-20 Clifton Life Sciences LLC Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm

Also Published As

Publication number Publication date
BR112017005279A2 (pt) 2017-12-12
CA2959670A1 (en) 2016-03-24
DK3929303T3 (da) 2025-03-03
KR20250021631A (ko) 2025-02-13
ES2881474T3 (es) 2021-11-29
AU2015317893B2 (en) 2021-05-20
JP7157788B2 (ja) 2022-10-20
US20190345568A1 (en) 2019-11-14
WO2016044330A1 (en) 2016-03-24
MX386919B (es) 2025-03-19
JP6782700B2 (ja) 2020-11-11
DK3194618T3 (da) 2021-07-12
US20160076106A1 (en) 2016-03-17
CN107208132A (zh) 2017-09-26
ES3013599T3 (en) 2025-04-14
AU2021212151A1 (en) 2021-08-26
EP3194618A1 (en) 2017-07-26
MX2021012347A (es) 2021-10-22
PL3194618T3 (pl) 2021-12-13
IL250867A0 (en) 2017-04-30
US20220325351A1 (en) 2022-10-13
EP3929303A1 (en) 2021-12-29
IL281355A (en) 2021-04-29
EP3194618B1 (en) 2021-04-21
US12258633B2 (en) 2025-03-25
AU2023258444A1 (en) 2023-11-23
US10407730B2 (en) 2019-09-10
MX2017003370A (es) 2017-11-22
KR20170045365A (ko) 2017-04-26
JP2017528164A (ja) 2017-09-28
EP3929303B1 (en) 2024-12-04
KR102762958B1 (ko) 2025-02-04
AU2021212151B2 (en) 2023-08-03
JP2021019618A (ja) 2021-02-18
AU2015317893A1 (en) 2017-03-23
CA2959670C (en) 2024-02-20
US11168372B2 (en) 2021-11-09
IL250867B (en) 2021-03-25
IL281355B (en) 2022-02-01

Similar Documents

Publication Publication Date Title
IL250867A0 (en) Preparations, methods and kits for diagnosing gastroenteropancreatic neuroendocrine tumor
EP3185748A4 (en) Evaluating test taking
GB2524479B (en) Testing rig
GB201403096D0 (en) Sample preparation method
EP3093668A4 (en) Automated analyzer
GB201411060D0 (en) Improved immunoassay method
GB201421920D0 (en) Software test automation
EP3176587A4 (en) Automated analyzer
EP3121586A4 (en) Fatigue tester
IL246889A0 (en) A method for measuring engagement
EP3136101A4 (en) Method of testing for pulmonary hypertension
ZA201606324B (en) Method for diagnosing tuberculosis
EP3225995A4 (en) Inspection kit
GB201509559D0 (en) Lubricant test method
EP3188701A4 (en) Reduction kits
AU2015343095B2 (en) Application testing
GB201615417D0 (en) Fluoometric analyzer
ZA201607571B (en) Compositions and methods for detecting huanglongbing
IL264542A (en) Diagnostic methods for gynecological tumors
EP3137874B8 (fr) Procédé de diagnostic de la méningite
GB201400756D0 (en) Blisk
EP3137886A4 (en) Xrf analyzer
GB2548042B (en) Real-time performance analyzer for drilling operations
EP3174377A4 (en) Inspection method
GB201414419D0 (en) Method of testing